FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Rhyz Analytical Labs CGMP Violations

FDA warns Provo, UT-based Rhyz Analytical Labs about CGMP violations in its work as a contract testing laboratory.

Human Drugs

Multiple Turbare Manufacturing Violations

FDA warns Conway, AR-based Turbare Manufacturing about CGMP and other violations in its work as an outsourcing facility producing sterile drug product...

latest-news-card-1
Human Drugs

QTc Information Labeling Guidance

FDA publishes a guidance to assist applicants in incorporating heart rate-corrected (QTc) interval of prolongation-related information in the labeling...

latest-news-card-1
Human Drugs

Judge Strikes Down FDA Decision Blocking Priority Voucher

A Washington, DC, federal judge rules that FDA acted unlawfully when it denied a priority review voucher to Sun Pharma and its drug Sezaby, the first ...

latest-news-card-1
Human Drugs

New CDER Director Pazdur Files Retirement Papers

Weeks into his new appointment, CDER director Richard Pazdur files paperwork to retire by the end of the month.

latest-news-card-1
Human Drugs

FDA Alert on Abbott Glucose Monitor Sensors

FDA issues an early alert concerning certain Abbott Diabetes Care glucose monitor sensors, warning patients and healthcare providers about potentially...

latest-news-card-1
Human Drugs

Hi-Tech Pharma CEO Convicted in GMP Fraud Scheme

Government prosecutors win guilty conviction against Hi-Tech Pharmaceuticals CEO and twice-convicted felon Jared Wheat for orchestrating a years-long ...

latest-news-card-1
Human Drugs

House OKs Rare Pediatric Disease Voucher Program

The House approves legislation reauthorizing the FDA Pediatric Rare Disease Priority Review Voucher program and giving the agency the authority to ord...

latest-news-card-1
Human Drugs

Monoclonal Antibody Streamlined Safety Study Guidance

FDA publishes a draft guidance on streamlined nonclinical safety studies for monoclonal antibodies.

latest-news-card-1
Human Drugs

FDA Safety Alert on Some BD Alaris Pump Modules

FDA issues a safety alert after Becton Dickinson recently recalled (Class 1 device correction) certain Alaris Pump Modules if they have been dropped o...